title: Reply to F.V. Negri et al.
authors.affiliation: Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China slye@shmu.edu.cn.
authors.forename: Sheng-Long
authors.initials: SL
authors.lastname: Ye
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004655:Emulsions / Q000008:administration & dosage*; D005260:Female; D060831:Hand-Foot Syndrome / Q000517:prevention & control*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000009:adverse effects*; D014508:Urea / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D004655:Emulsions; D010671:Phenylurea Compounds; D009536:Niacinamide; D014508:Urea